Altaire Recalls Neo-Polycin Ophthalmic Ointment Due to Sterility Concerns
Altaire Pharmaceuticals is recalling Neo-Polycin ophthalmic ointment due to a lack of assurance of sterility. The recall covers 121,572 containers distributed nationwide.
- Product
- Perrigo Neo-Polycin neomycin and polymixin B sulfates and bacitracin zinc Ophthalmic Ointment Net Wt. 3.5 g, Rx only, Manufactured for Perrigo Minneapolis, MN 55427 NDC 0574-4250-35
- Category
- Drug
- Distribution
- Distributed nationwide